Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
p53 Breast Cancer Trial
NCT02965950Phase 2Active, not recruiting
- Sponsor
- Haukeland University Hospital
- Start
- Oct 2016
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in breast cancer, sponsored by Haukeland University Hospital. Started Oct 2016; status: active, not recruiting.
02
Drugs
cyclophosphamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02965950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02965950.